Company intelligence / Profile preview

Sure

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Sure Bio-Tech manufactures and supplies a broad range of in vitro diagnostic devices and reagents for infectious disease screening and confirmation as well as fertility and TORCH testing. Their products are CE-marked and intended for export markets outside the United States. The company has over 18 years of experience in IVD manufacturing with integrated R&D and production capabilities supporting global distribution channels. No clinical trial results are reported since these are commercial diagnostic products.

Therapeutic areas: Women's HealthInfectious DiseasesOther
Modalities: DeviceDiagnostic reagent
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Sure.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sure.

Explore the full profile